PhD| Scientist, Researcher, Team Leader | Dedicated to promoting quality, innovative and affordable healthcare for all
Cincinnati, OH
Joined July 2009
- Tweets134
- Following679
- Followers131
- Likes473
I received my 2nd dose of Pfizer's COVID vaccine yesterday. 17 hours and I haven't experienced any adverse reactions. Only mild soreness in my left SHOULDER. Some get fevers, but they quickly resolve 24hrs later so worth it. Never miss opportunity to get a vaccine.
While the spreading SARS-CoV-2 variants are concerning, the immune systems in vaccinated people are still primed for strong responses that prevent severe illness and death. Bottom line: Vaccines still work, never miss an opportunity to get a vaccine. theatlantic.com/science/arch…
Matthew de Gannes retweeted
Really good data demonstrating what happened with herd immunity from natural infection approach. Lots of people die, the virus evolves and the it happens again. thelancet.com/journals/lance…
Matthew de Gannes retweeted
Every year, Bill and I write a letter with our perspective on how to meet the world’s most pressing challenges.
Our 2021 letter is about how the world can bring an end to COVID-19 and turn the hard-won lessons of this pandemic into a healthier, more equal future for all.
It was an early, cold Saturday morning, but the first dose of the Pfizer vaccine was definitely work it. It was as quick and easy as turning on a light switch, and still don't feel a thing 3 hours later. Second dose is in 3 weeks. To making the community safer 🍻
Matthew de Gannes retweeted
A brief reminder that if vaccines could alter your DNA we would have used them to cure a few dozen genetic diseases by now. 🤨
Thank-you.
Humbled by the opportunity to share my research journey, courtesy my latest "alma mater"- University of Cincinnati. Like many PhD students, my journey has many bends in the road, but I relished the learning and the lifelong friendships. So here it is. Thank you UC 😊❤️.
A decades old epidemic inspires UC doctoral student’s journey into science. Twists and turns end with a rewarding finish for College of Medicine graduate and Trinidad native, Matthew de Gannes. Read his story: on.uc.edu/34481fn #UCGrad20
All individuals, whether previously diagnosed with COVID-19 or not, should take identical precautions to avoid infection (or reinfection) with SARS-CoV-2. The implications of reinfections could be relevant for vaccine development and application. thelancet.com/journals/lanin…
Excellent move by Moderna, recognizing that this pandemic is bigger than the whims of capitalism, and all of us.
While the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic. Read our statement here: buff.ly/3ntU6qV
Mission: Get PhD....COMPLETE. It is finally over, all the emotional roller coasters, the struggle, the challenges could not have been overcome without the positive group of dedicated, committed scientists from my lab, friends, colleagues and family. It's been a rewarding journey.
Matthew de Gannes retweeted
You can’t use reason to convince anyone out of an argument that they didn’t use reason to get into.
Matthew de Gannes retweeted
U.S. Coronavirus Rates Are Rising Fast Among Children - The New York Times nytimes.com/interactive/2020…
Matthew de Gannes retweeted
Please #WearAMask whenever you’re in public. In doing so, you can help save children fighting cancer and other life-threatening diseases at St. Jude. stjude.org/Cover-For-The-Kid…
Further evidence supporting the use of big data, machine learning, and analytics in improving precision therapies that deliver higher quality, more targeted healthcare at affordable costs. #ValueBasedMedicine
The results of Brigham Hyde’s latest study using predictive analytics and machine learning showcased new ways to improve and manage patient outcomes and treatment pathways and increased the value of hub performance. ow.ly/ft5N30qXpAv
Vaccines targeting the S protein will certainly not be the "be all, end all." A new approach targeting other epitopes that generate a stronger T cell response appears more promising for long-term immunity. drugtargetreview.com/news/66…
Matthew de Gannes retweeted
Everyone is struggling with how to get back to work, back to school, back to campus. Here's some of our thinking on how to get our Universities back safely. @califf001 @VindellW @verilylifesci @cbwang @ASlavitt
What are your campuses planning to do?
chronicle.com/article/the-ba…
Matthew de Gannes retweeted
COVID testing: Cheap, quick, at-home rapid test is needed, experts say amp.usatoday.com/amp/5491744…
Leverage a year of uncertainty into becoming empowered to influence our leaders into making policy using models that make healthcare affordable while maintaining an innovative market. Watch @icer_review 's webinar series on proposed models here: us02web.zoom.us/webinar/regi…
Matthew de Gannes retweeted
This article-in-press from authors @erasmusuni @LSEnews & @UniOfYork provides an important methodological contribution outlining how future unrelated medical costs can be included in health technology assessment. #FutureCosts #HTA #EconomicEvaluation ow.ly/RlNb50ADuTW
Dr. Fauci gets a lot of press, but Kizzmekia Corbett is NIH's leading researcher on COVID-19 vaccine development. Check out her interview and publications below. #AmplifyBlackSTEM #citeBlackSTEM pubmed.ncbi.nlm.nih.gov/?ter…
youtube.com/watch?v=a09PhAqw…